Preoperative adjuvant transarterial chemoembolization cannot improve the long term outcome of radical therapies for hepatocellular carcinoma

@inproceedings{Jianyong2017PreoperativeAT,
  title={Preoperative adjuvant transarterial chemoembolization cannot improve the long term outcome of radical therapies for hepatocellular carcinoma},
  author={Lei Jianyong and Zhong Jinjing and Yan Lunan and Zhu Jingqiang and Wang Wentao and Zeng Yong and Li Zhi Bo and Wen Tianfu and Yang Jiaying},
  booktitle={Scientific reports},
  year={2017}
}
Combinations of transarterial chemoembolization (TACE) and radical therapies (pretransplantation, resection and radiofrequency ablation) for hepatocellular carcinoma (HCC) have been reported as controversial issues in recent years. A consecutive sample of 1560 patients with Barcelona Clinic Liver Cancer (BCLC) stage A/B HCC who underwent solitary… CONTINUE READING